Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Agilon Health, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by claims that Agilon Health may have misled investors regarding its business performance [1]. - Shareholders who purchased Agilon Health securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. Group 2: Company Performance - On August 4, 2025, Agilon Health announced its second quarter results, indicating that industry headwinds were more severe than previously anticipated [3]. - Following this announcement, Agilon Health's stock experienced a significant decline of 51.5% on August 5, 2025 [3]. Group 3: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has a history of achieving substantial settlements for investors, including over $438 million in 2019 alone [4].

Core Points - Chipotle Mexican Grill has launched the Chipotle U Rivalry Week program to engage college towns in the U.S. by rewarding the top ten towns that recruit the most new Chipotle U Rewards members with a BUY-ONE-GET-ONE (BOGO) offer [1][2][4] Group 1: Program Details - The program features a live microsite and leaderboard for students to track their college town's progress in recruiting new members [1][3] - The competition runs from November 10 to November 17, 2025, and all U.S. college towns are eligible to participate [6][7] - The top ten college towns will receive a BOGO offer for their students, which will be directly added to the wallets of Chipotle U Rewards members [3][7] Group 2: Incentives for Participation - College students can earn 1,000 bonus points upon enrolling in Chipotle U Rewards and receive 20% more points on every purchase, allowing them to earn free Chipotle faster [4] - The BOGO offer is limited to one free menu item with the purchase of an entrée of equal or greater value and is redeemable in-restaurant only [5] Group 3: Company Background - Chipotle operates over 3,900 restaurants across the U.S., Canada, the U.K., France, Germany, and the Middle East, and is committed to serving responsibly sourced food without artificial ingredients [9]

Core Viewpoint - Rosen Law Firm is encouraging investors of aTyr Pharma, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the aTyr Pharma securities class action is from January 16, 2025, to September 12, 2025 [2]. - Investors who purchased common stock during this period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by December 8, 2025 [4]. Group 2: Legal Representation - Investors are advised to choose qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The complaint alleges that aTyr Pharma provided misleading statements regarding the efficacy of its drug Efzofitimod, particularly concerning its ability to allow patients to taper steroid usage completely [6]. - The lawsuit claims that when the true information became public, investors suffered damages as a result [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [1] Group 1: Legal Action and Stock Impact - Western Alliance Bancorporation disclosed a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [3] Group 2: Class Action Information - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, with Rosen Law Firm preparing to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being ranked highly for its success in this area [4]

Core Viewpoint - Lantheus Holdings, Inc. is facing a securities class action lawsuit due to allegations of providing misleading statements regarding its product Pylarify, with a lead plaintiff deadline set for November 10, 2025 [1][5]. Group 1: Class Action Details - The class action pertains to investors who purchased Lantheus securities between February 26, 2025, and August 5, 2025, and may be entitled to compensation without upfront fees [2][5]. - A lawsuit has already been filed, and interested parties must act by the November 10, 2025 deadline to serve as lead plaintiff [3][5]. Group 2: Allegations Against Lantheus - The lawsuit claims that Lantheus made overly positive statements while concealing material adverse facts about Pylarify's competitive position [5]. - It is alleged that Lantheus failed to adequately assess pricing dynamics and that a price increase in early 2025, despite previous price erosion, risked Pylarify's market position and revenue potential [5]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel, highlighting its track record in securities class actions and significant settlements [4]. - The firm has recovered hundreds of millions for investors, including over $438 million in 2019, and has been consistently ranked among the top firms in this area since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Molina's management failed to disclose several material adverse facts, including issues related to medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that the positive statements made by Molina's management regarding the company's business and prospects were materially misleading [5].

Core Viewpoint - Rosen Law Firm is urging investors of James Hardie Industries plc to seek legal counsel before the December 23, 2025 deadline for a securities class action lawsuit related to misleading statements about the company's North America Fiber Cement segment [2][6]. Group 1: Class Action Details - The class action pertains to investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, and may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A lawsuit claims that James Hardie misled investors regarding the strength of its North America Fiber Cement segment, falsely asserting that demand was strong while distributors were actually destocking inventory [6]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of successful settlements in securities class actions, including a record settlement against a Chinese company and significant recoveries for investors in previous years [5].

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit on behalf of investors who purchased Synopsys, Inc. securities during the specified Class Period, highlighting the potential for compensation without upfront costs for affected investors [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to Synopsys, Inc. securities purchased between December 4, 2024, and September 9, 2025 [1]. - Investors wishing to serve as lead plaintiffs must file their motion by December 30, 2025 [1][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, noting their own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements, including the largest securities class action settlement against a Chinese company and being ranked highly for securities class action settlements [4]. Group 3: Allegations Against Synopsys - The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business operations and financial prospects, particularly concerning its focus on artificial intelligence customers [5]. - Specific claims include the negative impact of these decisions on the company's financial results and the misleading nature of positive statements made by the defendants [5].

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Lantheus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Actions and Investigations - Shareholders who purchased Telix securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - On July 22, 2025, Telix received a subpoena from the U.S. Securities and Exchange Commission regarding disclosures related to its prostate cancer therapeutic candidates, leading to a 10.44% drop in the price of Telix's American Depositary Shares on July 23, 2025 [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has been recognized for its significant settlements, including over $438 million recovered for investors in 2019 and being ranked among the top firms for securities class action settlements since 2013 [4].